Author(s): Patton JP, Nash DB, Abrutyn E, Patton JP, Nash DB, Abrutyn E, Patton JP, Nash DB, Abrutyn E, Patton JP, Nash DB, Abrutyn E
Abstract Share this page
Abstract Urinary tract infection results in significant morbidity and mortality while consuming large amounts of national resources. The prevention, diagnosis, and treatment of urinary tract infection produce both costs and benefits, and economic analysis provides a rational framework for looking at these effects. The goals and methods of economic analysis in medicine are summarized, and strategies to address uncomplicated cystitis, nosocomial urinary tract infection, and pyelonephritis are reviewed, with an emphasis on the economic trade-offs faced by decision makers.
This article was published in Med Clin North Am
and referenced in Clinical Microbiology: Open Access